Gender Difference of Metabolic Syndrome and Its Association Between Dietary Diversity at Different Ages
China Nutrition and Health Survey
1 other identifier
observational
4,308
0 countries
N/A
Brief Summary
With the development of economics in China, the dietary diversity got higher. Meanwhile, the prevalence of metabolic syndrome (MetS) raised up as well. To investigate the gender difference of getting MetS and its various associations with dietary diversity at different ages.Data of adults(n=4308) aged 18+ y with three consecutive 24-h recalls and complete co-variates information were extracted from Chinese Nutrition and Health Survey in 2009. Modified Dietary Diversity Score (DDS) was adopted to capture the diversity of diet. MetS was defined by the harmonized criteria. Multivariable adjusted logistic regression was carried out to detect the association between DDS and MetS and its components for young, middle aged and elderly adults by a cross-sectional study. More detailed information can be found in Pubmed,PMID: 24341753 (The China Health and Nutrition Survey, 1989-2011.).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2009
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2017
CompletedFirst Submitted
Initial submission to the registry
July 26, 2017
CompletedFirst Posted
Study publicly available on registry
August 2, 2017
CompletedAugust 2, 2017
August 1, 2017
12 months
July 26, 2017
August 1, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Metabolic syndrome
MetS was defined according to the harmonized definition of the International Diabetes Federation and other organizations , that three or more out of five following criteria are considered as MetS: (1) central adiposity (WC \>102 cm in men and \>88cm in women); (2) serum HDL-C \< 50 mg/dL in women or \< 40 mg/dL in men; (3) serum triglyceride levels \> 150 mg/dL; (4) SBP ≥ 130mm Hg or DBP ≥ 85mm Hg; (5) fasting plasma glucose ≥100 mg/dL.
through study completion, an average of 1 year
Study Arms (2)
male
young (≥18 and ≤45), adult (45\~60), and old (\>60) , n=1960
female
young (≥18 and ≤45), adult (45\~60), and old (\>60) , n=2348
Eligibility Criteria
Finally, 4308 participants were included in the present study, of which 2348 are female, and 1960 are male.
You may qualify if:
- In the present study, participants were extracted from 2009, as the biochemical data was only available in 2009. Only adults (≥18 years old) with complete information on food consumption and biochemical data were included in our analysis (n=5118).
You may not qualify if:
- We excluded women who were pregnant or lactating (n=41). To avoided the distortion of outlier, adults with implausible daily energy intake (\>7000kcal or \<520kcal) were censored (n=4). Meanwhile, adults who have a history of metabolic related disease, such as myocardial infarction (n=15), diabetes (n=90), and apoplexy (n=31) were excluded, because their diet might be changed after diagnostic disease. In addition, we also excluded people who take antihypertensive drugs (n=507). After matching food data with biochemical and anthropometric data and biochemical data, individuals with incomplete information was removed (n=122).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hui Wang, Dr
Nanjing Medical University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 26, 2017
First Posted
August 2, 2017
Study Start
January 1, 2009
Primary Completion
December 31, 2009
Study Completion
July 1, 2017
Last Updated
August 2, 2017
Record last verified: 2017-08
Data Sharing
- IPD Sharing
- Will not share
The bio-marker data is confidential, researchers need to apply for the analysis.